Pulmonary Research and Innovation :: Nationwide Children's Hospital

Pulmonary Research and Innovation

In addition to providing outstanding clinical care, members of the Section of Pulmonary Medicine conduct research and lead clinical trials to improve patient outcomes.

Nationwide Children’s is part of two large, national research networks through the Cystic Fibrosis Foundation and the American Lung Association.

Pulmonary Clinical Studies

Clinical researchers at Nationwide Children's are committed to identifying new approaches for the prevention, diagnosis and treatment of childhood diseases, taking research discoveries from the lab to the patient's bedside.

Get the Latest

Hospitals Should Use Genotyping to Monitor Bacterial Infections
A team led by a pulmonologist-researcher found that in a children's hospital, an unexpected pathogen emerges as a common cause of infection.

An Easier Way to Calculate Sinus Disease Severity in Patients with Cystic Fibrosis
The new Sheikh-Lind scoring system allows radiologists, pulmonologists and ear, nose and throat specialists to “speak the same language” about CT scans and quickly apply findings to the clinic.

A Graft Ischemic Time “Sweet Spot” in Lung Transplants for Children with CF
Ischemia times of 4 to 6 hours are associated with better long-term survival than both shorter and longer ischemia times.

Specialty Pharmacy for Cystic Fibrosis Improves Access to Medication
In a project started to increase the number of patients taking Orkambi, access and adherence increases for all medications.

Pulmonary Medicine’s Collaboration in a Comprehensive Muscular Dystrophy Clinic
The multi-disciplinary approach eases coordination of care, physician communication and the travel burden on families.

Light Therapy Associated with Shorter Length of Stay for Hospitalized Cystic Fibrosis Patients
Decreased depressive symptoms and improved quality of life indicators also seen after the simple treatment.

ECMO Helps Children Survive to Receive a Lung Transplant, with No Sign of Worse Outcomes Long Term
Finding raises question of how priority for donor organs should be given.

Case Study: ABCA3 Surfactant Disorder
Surfactant disorders are a leading cause of lung transplants, but monthly corticosteroid infusions can delay transplant indefinitely for some patients.

Helping Adolescents Take the Reins on Their Cystic Fibrosis Care
New CF transition pathway aims to produce health care consumers who are well suited and prepared to be part of their health care team.

Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000